BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
QuintilesIMS
US Army
US Department of Justice
Mallinckrodt
Teva
Cantor Fitzgerald
Queensland Health
Express Scripts

Generated: January 19, 2018

DrugPatentWatch Database Preview

MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Mefoxin In Sodium Chloride 0.9% In Plastic Container patents expire, and what generic alternatives are available?

Mefoxin In Sodium Chloride 0.9% In Plastic Container is a drug marketed by Merck and is included in one NDA.

The generic ingredient in MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefoxitin sodium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Drug patent expirations by year for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

US Patents and Regulatory Information for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-002 Sep 20, 1984 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-001 Sep 20, 1984 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fuji
Cantor Fitzgerald
Argus Health
Express Scripts
QuintilesIMS
Federal Trade Commission
Novartis
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot